Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, May 2008

Sort by: Newest first Oldest first A-Z Z-A

  • Prescribing training for medics

    24 MAY 2008 11:53

    The British National Formulary is at the centre of a new online learning tool for medical students.The BNF Prescribing Practice resource provides a range of case studies to help students improve their prescribing knowledge.

  • Scottish palliative care

    24 MAY 2008 11:53

    Palliative care model schemes will continue in Scotland, following a 2008–09 funding announcement for NHS boards made in May 2008 by the Scottish Government.The funding is not recurring and arrangements for future years — including how the schemes will integrate with the new community pharmacy contract — are still to be decided.

  • Long-term funding for IM&T support announced in Scotland

    24 MAY 2008 11:53

    New funding for primary care information management and technology (IM&T) facilitators was announced in May 2008 by the Scottish Government. The facilitators support pharmacists, doctors and dentists with the IM&T aspects of their respective contracts in Scotland.

  • Online medicines management training wins IT award for Northumbrian hospital trust

    24 MAY 2008 11:53

    An online medicines management training programme for hospital staff, developed by pharmacists, has won national recognition.

  • Antihypertensive therapy

    Benefits of antihypertensives independent of age

    24 MAY 2008 11:53

    The benefits of reducing blood pressure with various antihypertensive drugs are independent of patients’ ages, according to research published in the BMJ (2008;336:1121).

  • Guanfacine reduces ADHD symptoms

    24 MAY 2008 11:53

    Guanfacine, a selective alpha2A-adrenoceptor agonist, has been shown to reduce symptoms of attention deficit hyperactivity disorder (ADHD) in clinical trials.

  • New development programme

    24 MAY 2008 11:53

    AstraZeneca’s AZD0424, a tyrosine kinase inhibitor, is the first drug to enter Cancer Research UK’s clinical development partnerships programme.The programme was launched to support the development of promising anticancer agents by offering companies an alternative to traditional out-licensing. The manufacturer retains rights to the drug throughout its development.

  • Hope for pulmonary fibrosis

    24 MAY 2008 11:53

    Pirfenidone, an anti-inflammatory and antifibrotic compound, stabilises lung function and improves progression-free survival in patients with idiopathic pulmonary fibrosis, according to a phase III study presented at the American Thoracic Society’s international conference in Toronto in May 2008.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.